Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients (ERSD)

NCT03539861 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03539861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03539861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients (ERSD)
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Terminated
Start date
September 24, 2019
Completion date
August 4, 2021
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, chronic kidney disease stage 5, end stage renal disease